Amphotericin B increases influenza A virus infection by preventing IFITM3-mediated restriction

Tsai-Yu Lin1, Christopher R Chin2, Aaron R Everitt3

  • 1Department of Microbiology and Physiological Systems, University of Massachusetts Medical School, Worcester, MA 01655, USA.

Cell Reports
|November 26, 2013
PubMed

Insights

Amphotericin B (AmphoB), an antifungal drug, unexpectedly enhances influenza A virus (IAV) replication by blocking IFITM3's antiviral activity. This finding suggests patients on AmphoB therapy may be more vulnerable to IAV infections.

Area of Science:

  • Virology
  • Immunology
  • Pharmacology

Background:

  • Interferon-induced transmembrane proteins (IFITMs) are crucial for innate immunity against influenza A virus (IAV).
  • IFITM3 specifically restricts IAV replication, contributing to host defense.
  • The precise mechanisms by which IFITMs exert their antiviral effects are still being elucidated.

Purpose of the Study:

  • To investigate the effect of the antifungal drug amphotericin B (AmphoB) on IFITM-mediated restriction of IAV.
  • To determine if clinical preparations of AmphoB impact host defense against IAV.
  • To elucidate the mechanism by which AmphoB interferes with IFITM antiviral activity.

Main Methods:

  • In vitro assays measuring IAV replication in the presence of IFITM proteins and AmphoB.
  • In vivo studies using a mouse model of IAV infection treated with AmBisome (a clinical AmphoB preparation).
  • Analysis of host membrane fluidity in response to IFITM1 expression and AmphoB treatment.

Main Results:

  • AmphoB and its clinical formulation AmBisome prevent IFITM3-mediated restriction of IAV, leading to increased viral replication.
  • AmphoB neutralizes the protective effect of interferon against IAV in vitro.
  • IFITM1 was found to decrease host membrane fluidity, a property negated by AmphoB.
  • Mice treated with AmBisome exhibited increased susceptibility to IAV infection, mirroring outcomes in Ifitm3-deficient mice.

Conclusions:

  • AmphoB interferes with the antiviral functions of IFITM proteins, particularly IFITM3.
  • Clinical use of AmphoB may compromise host defense against IAV and potentially other IFITM3-restricted viruses.
  • Patients undergoing antifungal therapy with AmphoB may be functionally immunocompromised, increasing their vulnerability to viral infections.

Related Concept Videos

Antifungal Agents01:15

Antifungal Agents

Amphotericin B is a broad-spectrum antifungal agent that exploits structural differences between fungal and mammalian cell membranes. Its amphipathic structure—featuring a hydrophobic polyene-lactone ring and a hydrophilic region containing mycosamine and carboxylic acid groups—enables selective binding to ergosterol, a sterol predominantly found in fungal plasma membranes. This selective interaction underlies the drug’s antifungal activity, although weak binding to...
131
Influenza01:27

Influenza

Influenza is an acute, highly communicable viral disease that affects the respiratory tract and is responsible for seasonal epidemics worldwide. Influenza A is the most prevalent type associated with widespread outbreaks and is subtyped based on two surface glycoproteins: hemagglutinin (H) and neuraminidase (N), as in H1N1. These glycoproteins are essential for viral infectivity, transmission, and immune recognition. Transmission occurs primarily through respiratory droplets and contaminated...
101
Antimicrobial Proteins01:23

Antimicrobial Proteins

Antimicrobial proteins are important components of the immune system. They aid the body in combating pathogens by either killing them directly or hindering their replication processes. Four main types of antimicrobial substances are interferons, the complement system, iron-binding proteins, and antimicrobial proteins.
Interferons
Interferons (IFNs) are proteins produced by lymphocytes, macrophages, and fibroblasts infected with viruses. While IFNs cannot prevent viruses from entering and...
10.6K
Inhibitors of Viral Protein Synthesis01:30

Inhibitors of Viral Protein Synthesis

Protein synthesis is indispensable for viral replication, as viruses lack the cellular machinery required for this process and must hijack the host's translational apparatus. In response, host cells deploy a critical innate immune defense involving interferons, specialized cytokines that play a central role in inhibiting viral propagation.Upon viral detection, infected cells release interferons that bind to receptors on adjacent uninfected cells, activating the JAK-STAT signaling pathway and...
73
Leaky Scanning02:28

Leaky Scanning

During most eukaryotic translation processes, the small 40S ribosome subunit scans an mRNA from its 5' end until it encounters the first start AUG codon. The large 60S ribosomal subunit then joins the smaller one to initiate protein synthesis. The location of the translation initiation is largely determined by the nucleotides near the start codon as there may be multiple translation initiation sites present on the mRNA.  Marilyn Kozak discovered that the sequence RCCAUGG (where R...
4.5K
Immune Response Against Viral Pathogens01:29

Immune Response Against Viral Pathogens

The immune system's response to viral infections is a complex and coordinated process involving natural killer (NK) cells, T cell-mediated responses, and antibody-mediated responses.
NK Cells
NK cells are a crucial part of our innate immune system, acting as the first line of defense against viral infections. These cells can recognize and kill infected cells without prior exposure to the virus, effectively slowing down the spread of infection. Additionally, NK cells produce proinflammatory...
2.4K